NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/26/2024
Back to search
Official data from USPTO
DESIGNCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DESIGNCELL
ST13
US500000097718944Class
1, 5, 42, 44
Filing
97718944
Registration
7335729
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
03/26/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
12/15/2022
Registration date
03/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2024
Last transaction
03/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
STANWOOD, STEPHEN
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hitachi, Ltd.
Representatives
Jill Anderfuren LEWIS BRISBOIS BISGAARD & SMITH LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research or scientific purposes; stem cellsother than for medical or veterinary purposes
Class 5
Stem cells for medical purposes; living cells for medical or clinical use; living cells for medical use; living cells for medical usecells adapted for use in pharmaceutical preparations
Class 42
Stem cell research services; research in the field of cell engineering technology; development of pharmaceutical preparations and medicines in the field of cytology; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy in the field of cytology; testinginspectionresearch of pharmaceuticals; research and development services in the field of cytology; cell culture services for scientific and research purposesfor others; providing medical and scientific research information in the field of genetics and genetic engineering; quality control of pharmaceutical preparationsfor others
Class 44
Providing medical information; providing medical information in the field of stem cell therapy; stem cell bank services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2023
GNRT
NON-FINAL ACTION E-MAILED
11/29/2023
CNRT
NON-FINAL ACTION WRITTEN
11/29/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2023
GNRT
NON-FINAL ACTION E-MAILED
09/13/2023
CNRT
NON-FINAL ACTION WRITTEN
09/13/2023
DOCK
ASSIGNED TO EXAMINER
09/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2023
NWAP
NEW APPLICATION ENTERED
12/19/2022
Continuous trademark protection
Get notified about every new filing that threatens DESIGNCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.